Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota

The role of bacterial biofilms in chronic infections

(2013) Thomas Bjarnsholt   APMIS

Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection

(2013) A. Sarah Walker et al.   CLINICAL INFECTIOUS DISEASES

Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model

(2012) Pieter Van den Abbeele et al.   ISME Journal

Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model

(2012) C. H. Chilton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

(2012) G. S. Crowther et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection

(2012) P.N. Wiegand et al.   JOURNAL OF HOSPITAL INFECTION

Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts

(2012) Daniela Heeg et al.   PLoS One

Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A

(2012) Lisa F. Dawson et al.   PLoS One

The effects of hyperosmosis or high pH on a dual-species biofilm of Enterococcus faecalis and Pseudomonas aeruginosa: an in vitro study

(2011) S. V. van der Waal et al.   INTERNATIONAL ENDODONTIC JOURNAL

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model

(2009) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial‐Associated Risk Factors forClostridium difficileInfection

(2008) Robert C. Owens et al.   CLINICAL INFECTIOUS DISEASES

Control of cell fate by the formation of an architecturally complex bacterial community

(2008) H. Vlamakis et al.   GENES & DEVELOPMENT

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Physical and chemical factors influencing the germination ofClostridium difficilespores

(2008) L.J. Wheeldon et al.   JOURNAL OF APPLIED MICROBIOLOGY

Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores

(2008) J. A. Sorg et al.   JOURNAL OF BACTERIOLOGY